C5B7
C5B7
规格:
货期:
编号:TS212527
品牌:Testobio
| 产品名称： | C5B7 |
|---|---|
| 商品货号： | TS212527 |
| Organism： | Homo sapiens, human |
| Tissue： | spleen |
| Cell Type： | B lymphocyte; Epstein-Barr virus (EBV) transforme |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 Cells Contain HERPESVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody is specific for the lipopolysaccharide of the Fisher immunotype 1 of P. aeruginosa. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | B cells obtained from a patient with cystic fibrosis (whose serum contained above normal titer to P. aeruginosa) were transformed with Epstein-Barr virus (EBV). |
| Clinical Data： | B cells obtained from a patient with cystic fibrosis (whose serum contained above normal titer to P. aeruginosa) were transformed with Epstein-Barr virus (EBV). |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against Pseudomonas aeruginosa lipopolysaccharide (LPS) of Fisher immunotype 1 (IATS type 6) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against Pseudomonas aeruginosa lipopolysaccharide (LPS) of Fisher immunotype 1 (IATS type 6) |
| Comments： | B cells obtained from a patient with cystic fibrosis (whose serum contained above normal titer to P. aeruginosa) were transformed with Epstein-Barr virus (EBV). The antibody is specific for the lipopolysaccharide of the Fisher immunotype 1 of P. aeruginosa. |
| Complete Growth Medium： | Iscoves modified Dulbeccos medium with 2 mM L-glutamine, 85%; heat-inactivated fetal bovine serum, 15%
|
| Subculturing： | Medium Renewal: Every 3 to 4 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | Freeze medium: complete growth medium, 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| Isotype： | IgM |
| Population Doubling Time： | 24 to 36 hrs |
| Name of Depositor： | Miles Inc., Genetics Systems Corporation |
| Deposited As： | Homo sapiens |
| U.S. Patent Number： | |
| References： | Siadak AW, Lostrom ME. Human monoclonal antibodies to serotypic lipopolysaccharide determinants on Gram-negative bacteria and their production. US Patent 4,834,975 dated May 30 1989 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
C5B7
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | C5B7 |
|---|---|
| 商品货号： | TS212527 |
| Organism： | Homo sapiens, human |
| Tissue： | spleen |
| Cell Type： | B lymphocyte; Epstein-Barr virus (EBV) transforme |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 Cells Contain HERPESVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody is specific for the lipopolysaccharide of the Fisher immunotype 1 of P. aeruginosa. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | B cells obtained from a patient with cystic fibrosis (whose serum contained above normal titer to P. aeruginosa) were transformed with Epstein-Barr virus (EBV). |
| Clinical Data： | B cells obtained from a patient with cystic fibrosis (whose serum contained above normal titer to P. aeruginosa) were transformed with Epstein-Barr virus (EBV). |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against Pseudomonas aeruginosa lipopolysaccharide (LPS) of Fisher immunotype 1 (IATS type 6) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against Pseudomonas aeruginosa lipopolysaccharide (LPS) of Fisher immunotype 1 (IATS type 6) |
| Comments： | B cells obtained from a patient with cystic fibrosis (whose serum contained above normal titer to P. aeruginosa) were transformed with Epstein-Barr virus (EBV). The antibody is specific for the lipopolysaccharide of the Fisher immunotype 1 of P. aeruginosa. |
| Complete Growth Medium： | Iscoves modified Dulbeccos medium with 2 mM L-glutamine, 85%; heat-inactivated fetal bovine serum, 15%
|
| Subculturing： | Medium Renewal: Every 3 to 4 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | Freeze medium: complete growth medium, 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| Isotype： | IgM |
| Population Doubling Time： | 24 to 36 hrs |
| Name of Depositor： | Miles Inc., Genetics Systems Corporation |
| Deposited As： | Homo sapiens |
| U.S. Patent Number： | |
| References： | Siadak AW, Lostrom ME. Human monoclonal antibodies to serotypic lipopolysaccharide determinants on Gram-negative bacteria and their production. US Patent 4,834,975 dated May 30 1989 |
